Just a moment, the page is loading...
Welcome to the Janssen Oncology & Haematology IIS Website
Janssen Oncology
Selected Products:
Clear AllClose



Clinical Application Details


Drug:

Abiraterone acetate

Status:

Currently Accepting Clinical IIS Applications




Accepting applications for the review period between 1 April – 30 September 2019

PLEASE NOTE that the U.S. is not accepting any IIS concepts.

Click on "Submit Application" below to begin the process